Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.
Metabolic syndrome (MetS) comprises a clinical complex of patient risk factors, including increased waist circumference, high triglyceride levels, low high-density lipoprotein cholesterol level, high blood pressure, and insulin resistance, the presence of which increases the likelihood of developing diabetes and cardiovascular disease. With a quarter of the American adult population affected, MetS and type 2 diabetes mellitus have been referred to as the most significant public health threats of the 21st century. Lifestyle modification and weight loss are recommended, however, no specific pharmacologic treatment is known. Given that low levels of testosterone have been implicated in the pathogenesis of MetS and an inverse relationship exists between circulating testosterone levels and the development of MetS, it is tempting to speculate that men with MetS may benefit from testosterone supplementation therapy. As such, our review examines the role of testosterone and the use of testosterone supplementation therapy as a treatment in men with MetS.
Jason R
JR
Kovac
Scott Department of Urology and The Center for Reproductive Medicine, Baylor College of Medicine, Houston, TX. Kovac@bcm.edu.
Jason
J
Kovac
Alexander W
AW
Pastuszak
Dolores J
DJ
Lamb
Larry I
LI
Lipshultz
D000728:Androgens / Q000008:administration & dosage*; D006801:Humans; D008019:Life Style; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D009765:Obesity / Q000097:blood; D012738:Sex Hormone-Binding Globulin / Q000032:analysis; D013739:Testosterone / Q000008:administration & dosage* / Q000097:blood
D000728:Androgens; D012738:Sex Hormone-Binding Globulin; D013739:Testosterone